Back
Regeneron Pharmaceuticals Stock Price Chart
Sponsored
REGN
Sponsored
Stock Market Legend Shares Biggest Prediction Ever:
Click Here to See
Buy
60
REGN
Regeneron Pharmaceuticals
Last Price:
906.81
Seasonality Move:
10.55%
7 Day Trial
ALL ACCESS PASS
$
7
This DeFi Coin Could 10x Soon... I Advise You Get In Now!
Discover this DeFi diamond before the next surge- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and REGN is experiencing selling pressure, which indicates risk of future bearish movement.
Regeneron Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 899.74 | Buy |
20-day SMA: | 926.19 | Sell |
50-day SMA: | 950.16 | Sell |
200-day SMA: | 862.28 | Buy |
8-day EMA: | 905.83 | Buy |
20-day EMA: | 921 | Sell |
50-day EMA: | 933.13 | Sell |
200-day EMA: | 875.73 | Buy |
Regeneron Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -15.54 | Sell |
Relative Strength Index (14 RSI): | 37.33 | Sell |
Chaikin Money Flow: | -230214 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (906.04 - 962.06) | Sell |
Bollinger Bands (100): | (878.92 - 969.94) | Sell |
Regeneron Pharmaceuticals Technical Analysis
Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Regeneron Pharmaceuticals Stock
Is Regeneron Pharmaceuticals Stock a Buy?
- Regeneron Pharmaceuticals share price is 906.54 while REGN 8-day simple moving average is 899.74, which is a Buy signal.
- The stock price of REGN is 906.54 while Regeneron Pharmaceuticals 20-day SMA is 926.19, which makes it a Sell.
- Regeneron Pharmaceuticals 50-day simple moving average is 950.16 while REGN share price is 906.54, making it a Sell technically.
- REGN stock price is 906.54 and Regeneron Pharmaceuticals 200-day simple moving average is 862.28, creating a Buy signal.
REGN Technical Analysis vs Fundamental Analysis
Buy
60
Regeneron Pharmaceuticals (REGN)
is a Buy
Is Regeneron Pharmaceuticals a Buy or a Sell?
-
Regeneron Pharmaceuticals stock is rated a Buy
The current Regeneron Pharmaceuticals [REGN] share price is $906.54. The Score for REGN is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
Regeneron Pharmaceuticals Stock Info
Market Cap:
99.5B
Price in USD:
906.54
Share Volume:
369.72K
Regeneron Pharmaceuticals 52-Week Range
52-Week High:
998.33
52-Week Low:
684.81
Buy
60
Regeneron Pharmaceuticals (REGN)
is a Buy
Regeneron Pharmaceuticals Share Price Forecast
-
What is the Regeneron Pharmaceuticals stock price today?
The Regeneron Pharmaceuticals stock price is 906.54 USD today. -
Will REGN stock go up or go down?
Regeneron Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Regeneron Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Regeneron Pharmaceuticals is not overvalued.
Is Regeneron Pharmaceuticals Stock a Buy?
- Regeneron Pharmaceuticals share price is 906.54 while REGN 8-day exponential moving average is 905.83, which is a Buy signal.
- The stock price of REGN is 906.54 while Regeneron Pharmaceuticals 20-day EMA is 921.00, which makes it a Sell.
- Regeneron Pharmaceuticals 50-day exponential moving average is 933.13 while REGN share price is 906.54, making it a Sell technically.
- REGN stock price is 906.54 and Regeneron Pharmaceuticals 200-day simple moving average is 875.73, creating a Buy signal.
Fundamental Analysis of Regeneron Pharmaceuticals
Is Regeneron Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $1.25 per share, an increase next quarter of $0.01 per share, an increase this year of $2.51 per share, and an increase next year of $2.21 per share.
Technical Analysis of Regeneron Pharmaceuticals
Should I short Regeneron Pharmaceuticals stock?
- REGN Moving Average Covergence Divergence (MACD) indicator is -15.54, suggesting Regeneron Pharmaceuticals is a Sell
- Regeneron Pharmaceuticals Relative Strength Index (RSI) is 37.33, which suggest Regeneron Pharmaceuticals is oversold
- The Bollinger Bands (25) for Regeneron Pharmaceuticals is (906.04 - 962.06), which suggest Regeneron Pharmaceuticals is a Sell
- The Bollinger Bands (100) for Regeneron Pharmaceuticals is (878.92 - 969.94), which suggest Regeneron Pharmaceuticals is a Sell
* Regeneron Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.